ContraFect Corporation Confirms Appointment of Julia P. Gregory as CEO and Director, and Appoints David N. Low, Michael J. Otto and Roger J. Pomerantz to Board of Directors YONKERS, NY--(Marketwired - Apr 24, 2014) - ContraFect Corporation, a leader in the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant...

ContraFect Announces Management Team Changes YONKERS, NY--(Marketwired - Nov 21, 2013) -  ContraFect Corporation announced that Ms. Julia P. Gregory was appointed interim Chief Executive Officer, succeeding Dr. Robert Nowinski, the...

ContraFect to Present at the 5th Annual Biotech Showcase YONKERS, NY--(Marketwire - Jan 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert Nowinski, the Company's founder...

ContraFect to Present at the 11th Annual BIO Investor Forum YONKERS, NY--(Marketwire - Oct 3, 2012) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Julia P. Gregory, the Company's executive...

ContraFect Expands Senior Management Team YONKERS, NY--(Marketwire - Sep 12, 2012) - ContraFect Corporation announced today that it has expanded the senior management of the company with the addition of biotechnology veteran Julia Gregory...